Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events

Cates, Christopher J; Jaeschke, Roman; Schmidt, Stefanie; Ferrer, Montse (2013). Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane database of systematic reviews, 3(3), CD006922. Chichester: WileyInterscience

Full text not available from this repository. (Request a copy)

Epidemiological evidence has suggested a link between beta2-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe. This is an updated systematic review.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > University Psychiatric Services > University Hospital of Child and Adolescent Psychiatry and Psychotherapy

UniBE Contributor:

Schmidt, Stefanie Julia

ISSN:

1469-493X

Publisher:

WileyInterscience

Language:

English

Submitter:

Myriam Pyrlik

Date Deposited:

04 Oct 2013 14:42

Last Modified:

08 Jun 2016 10:35

PubMed ID:

23543548

URI:

https://boris.unibe.ch/id/eprint/17371 (FactScience: 225134)

Actions (login required)

Edit item Edit item
Provide Feedback